Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

948

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 2, 2016

Study Completion Date

December 2, 2016

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG

Rectal Indomethacin

DRUG

Epinephrine

Trial Locations (4)

21287

Johns Hopkins Medical Institutions, Baltimore

160012

Post Graduate Institute of Medical Education and Research, Chandigarh

500082

Asian Institute of gastroenterology, Hyderabad

700054

Apollo Gleneagles Hospitals, Kolkata

All Listed Sponsors
collaborator

American Society for Gastrointestinal Endoscopy

OTHER

collaborator

Asian Institute of Gastroenterology, India

OTHER

collaborator

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

collaborator

Apollo Gleneagles Hospitals, Kolkata

OTHER

lead

Johns Hopkins University

OTHER

NCT02116309 - Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis | Biotech Hunter | Biotech Hunter